Created in 1996 (Denmark), Actrapid is part of our Top Web Popularity Biotechnology, own 307 sister brands and 2214 competing brands. Actrapid is owned by NOVO-NORDISK A/S, listed on the stock exchange of Francfort Actrapid belongs to the Biotechnology business sector.

Actrapid is a brand of NOVO-NORDISK A/S (NOVA) Share price

Share price and profitability of the share NOVO-NORDISK A/S (Actrapid)

Buy NOVO-NORDISK A/S share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 118.50

Portfolio valuation
NOVO-NORDISK A/S (Actrapid) over 5 years* EUR 610.20

Stock market history NOVO-NORDISK A/S (Actrapid)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more